Provided by Tiger Trade Technology Pte. Ltd.

Mistras Group Inc

15.10
+0.19001.27%
Post-market: 15.100.00000.00%16:52 EDT
Volume:142.31K
Turnover:2.14M
Market Cap:476.38M
PE:28.49
High:15.22
Open:15.07
Low:14.90
Close:14.91
52wk High:15.84
52wk Low:7.06
Shares:31.55M
Float Shares:16.81M
Volume Ratio:0.70
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5300
EPS(LYR):0.5300
ROE:7.79%
ROA:6.04%
PB:2.03
PE(LYR):28.49

Loading ...

Mistras FY2025 Q3 Earnings Call Summary and Q&A Highlights: Strategic Diversification and Operational Efficiency Drive Growth

Earnings Call
·
Nov 07, 2025

Mistras (MG) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 07, 2025

Mistras Group Up Over 19%, on Pace for Largest Percent Increase Since April 2020 -- Data Talk

Dow Jones
·
Nov 06, 2025

MISTRAS Q3 revenue beats estimates

Reuters
·
Nov 05, 2025

MISTRAS Group Q3 Adj. EPS $0.46 Beats $0.29 Estimate, Sales $195.549M Beat $189.943M Estimate

Benzinga
·
Nov 05, 2025

BRIEF-MISTRAS Q3 Revenue USD 195.5 Million

Reuters
·
Nov 05, 2025

MISTRAS Group Reports Q3 Revenue of $195.5 Million and Net Income of $13.1 Million

Reuters
·
Nov 05, 2025

Mistras Q3 Adjusted Ebitda USD 30.2 Million

THOMSON REUTERS
·
Nov 05, 2025

Mistras Q3 Gross Margin 29.8%

THOMSON REUTERS
·
Nov 05, 2025

MISTRAS Announces Third Quarter 2025 Results

GlobeNewswire
·
Nov 05, 2025

Mistras Group Inc expected to post earnings of 30 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

Press Release: MG Properties Acquires Dockside Apartments in Kent, Washington for $95.6 Million

Dow Jones
·
Oct 31, 2025

CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China

GlobeNewswire
·
Oct 30, 2025

Mistras Group Inc expected to post earnings of 30 cents a share - Earnings Preview

Reuters
·
Oct 24, 2025

MISTRAS Group Inc. to Report Third Quarter Results

Reuters
·
Oct 23, 2025

MISTRAS Group Inc. to Present at Baird’s 55th Annual Global Industrial Conference

Reuters
·
Oct 16, 2025

MISTRAS Group Partners with Villari to Offer Wireless Crack-Detection Sensors for Critical Steel Assets

Reuters
·
Oct 14, 2025

Does MG-K10’s COPD Trial Approval Change the Bull Case for China Medical System Holdings (SEHK:867)?

Simply Wall St.
·
Oct 13, 2025

CMS (00867) Receives Clinical Trial Approval for Class 1 New Drug MG-K10 Humanized Monoclonal Antibody Injection for Chronic Obstructive Pulmonary Disease Indication

Stock News
·
Sep 30, 2025

China Medical System’s MG-K10 Receives Phase III Trial Approval for CSU

TIPRANKS
·
Sep 28, 2025